Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction
Status:
Completed
Trial end date:
2015-08-30
Target enrollment:
Participant gender:
Summary
Comparison of the efficacy and side effects of intravenous and oral regimens of dexamethasone
for prophylaxis of paclitaxel-associated hypersensitivity reactions in primary ovarian,
fallopian tube and peritoneal cancer patients receiving first cycle of combination paclitaxel
and carboplatin.